--- title: "Bank of China Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)" type: "News" locale: "en" url: "https://longbridge.com/en/news/285667787.md" description: "In a report released yesterday, from Bank of China maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$240.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In a report released yesterday, DBS also maintained a Buy rating on the stock with a HK$290.00 price target." datetime: "2026-05-08T05:26:28.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285667787.md) - [en](https://longbridge.com/en/news/285667787.md) - [zh-HK](https://longbridge.com/zh-HK/news/285667787.md) --- # Bank of China Sticks to Their Buy Rating for BeOne Medicines Ltd (6160) In a report released yesterday, from Bank of China maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$240.00. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In a report released yesterday, DBS also maintained a Buy rating on the stock with a HK$290.00 price target. ### Related Stocks - [06160.HK](https://longbridge.com/en/quote/06160.HK.md) - [03988.HK](https://longbridge.com/en/quote/03988.HK.md) - [601988.CN](https://longbridge.com/en/quote/601988.CN.md) - [ONC.US](https://longbridge.com/en/quote/ONC.US.md) - [688235.CN](https://longbridge.com/en/quote/688235.CN.md) - [D05.SG](https://longbridge.com/en/quote/D05.SG.md) - [02388.HK](https://longbridge.com/en/quote/02388.HK.md) - [BACHY.US](https://longbridge.com/en/quote/BACHY.US.md) - [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md) ## Related News & Research - [BeOne Medicines Ltd (6160) Gets a Buy from CMBC International](https://longbridge.com/en/news/285886964.md) - [BeOne Medicines Highlights Global Footprint With Latest Form 10-Q Filing](https://longbridge.com/en/news/285368026.md) - [UBS Sticks to Their Buy Rating for Aptiv (APTV)](https://longbridge.com/en/news/286947173.md) - [BeOne Medicines Issues Q1 2026 Unaudited Results and Cautious Guidance](https://longbridge.com/en/news/285365626.md) - [Yum China Holdings (YUMC) Gets a Buy from Bank of China](https://longbridge.com/en/news/285008256.md)